Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes

[1]  S. Strom,et al.  Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. , 1998, The New England journal of medicine.

[2]  D. Peterson,et al.  Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors , 1997, Nature Genetics.

[3]  A. Gown,et al.  Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors , 1997, Nature Genetics.

[4]  M. Kay,et al.  Expansion of donor hepatocytes after recombinant adenovirus‐induced liver regeneration in mice , 1997, Hepatology.

[5]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[6]  S. Korsmeyer,et al.  Molecular thanatopsis: a discourse on the BCL2 family and cell death. , 1996, Blood.

[7]  M. Grompe,et al.  Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I , 1996, Nature Genetics.

[8]  James M. Wilson.  Round two for liver gene therapy , 1996, Nature Genetics.

[9]  P. Galle,et al.  Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage , 1995, The Journal of experimental medicine.

[10]  R. Palmiter,et al.  Complete reconstitution of mouse liver with xenogeneic hepatocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Palmiter,et al.  Replacement of diseased mouse liver by hepatic cell transplantation. , 1994, Science.

[12]  R. Palmiter,et al.  Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene , 1991, Cell.

[13]  F D Ledley,et al.  Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Friend,et al.  HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS , 1969, The Journal of cell biology.

[15]  B. Viollet,et al.  Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice , 1996, Nature Medicine.